Drug Shortage Report for CYSTADROPS
Report ID | 109255 |
Drug Identification Number | 02485605 |
Brand name | CYSTADROPS |
Common or Proper name | Cysteamine solution |
Company Name | RECORDATI RARE DISEASES CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CYSTEAMINE |
Strength(s) | 0.37% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | one vial |
ATC code | S01XA |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-20 |
Estimated end date | 2020-04-20 |
Actual end date | 2020-04-14 |
Shortage status | Resolved |
Updated date | 2020-04-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3080 YONGE STREET, SUITE 6060 TORONTO, ONTARIO CANADA M4N 3N1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-04-20 | French | Compare |
v3 | 2020-04-20 | English | Compare |
v2 | 2020-03-23 | French | Compare |
v1 | 2020-03-23 | English | Compare |
Showing 1 to 4 of 4